This antibody component, one-tenth the size of a full-size antibody, has been used to create a drug called Ab8, which may be useful in treating or preventing a disease caused by SARS-COV-2 infection.

Coronavirus: the second wave

Half a year after the outbreak of the coronavirus pandemic in the spring, the second wave of the pandemic has arrived. The radical increase in the number of infected is forcing more and more countries to re-impose restrictions, despite the fact that the world economy has not even recovered from the effects of the spring outbreak. According to the posters, the second wave also reached Hungary. Follow our news!

A Cell In a study published in the scientific journal, the University of Pittsburgh School of Medicine reported that Ab8 has been shown to be very effective in preventing and treating SARS-COV-2 infection in mice and hamsters.

Its small size not only increases its ability to spread to tissues, better neutralizing the virus, but it also allows the drug to be delivered to the body alternatively, such as by inhalation. The researchers noted that because it does not bind to human cells, this may mean that it cannot have negative side effects in humans.

The efficacy of the new drug was evaluated by researchers from the University of North Carolina, the University of Texas and the University of British Columbia.

Ab8 may not only play a role in curing Covid-19 disease, but it can also be used to keep the new coronavirus infection away from humans, said John Mellors, a researcher at the University of Pittsburgh, a co-author of the study.

[Tényleg elpusztíthatja a szájvíz a koronavírust, csakhogy volna itt egy fontos “de”]

Larger antibodies have been shown to be effective against other infectious diseases and have been well tolerated by patients, raising hope that the drug will be effective in treating Covid-19 disease and protecting those who have not been. infected and developed immunity, he said. the.

If you want to know about similar things at other times, like the Facebook page in the HVG Tech section.



The number of independent publishing offices of power is steadily declining, and those that still exist are trying to stay afloat with a growing headwind. At HVG we persevere, we don’t give in to pressure and we bring national and international news every day.

That is why we ask you, our readers, to stand by us, support us, join our membership and renew it!

And we promise to keep doing our best for you in all circumstances!